Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis.

Erpolat Ö. P., AKMANSU M., Goksel F., BORA H., Yaman E., Buyukberber S.

Tumori, vol.95, no.2, pp.191-7, 2009 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 95 Issue: 2
  • Publication Date: 2009
  • Doi Number: 10.1177/030089160909500210
  • Journal Name: Tumori
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.191-7
  • Keywords: adjuvant, concomitant, glioblastoma, radiotherapy, temozolomide, PHASE-II, RADIATION-THERAPY, MULTIFORME, SURVIVAL, IRRADIATION, GLIOMAS, TRIAL
  • Gazi University Affiliated: Yes

Abstract

Aims and background. Glioblastoma is the most common primary brain tumor in adults. The standard treatment is surgery and radiotherapy. In this study, the results of radiotherapy plus concomitant and adjuvant temozolomide are reported. In addition, the efficiency of adjuvant temozolomide is evaluated.